newsfilter
← Latest News
ACCESS Newswire·

Revelation Biosciences Inc. Announces Cancellation of Adjournment of October 29, 2025 Special Meeting of Stockholders and New Record Date

  • Revelation Biosciences Inc. canceled the adjourned Special Meeting of Stockholders originally scheduled for October 29, 2025, due to technical difficulties preventing stockholders from voting.
  • The company established a new record date of October 29, 2025, for a rescheduled Special Meeting set to occur on December 3, 2025.
  • New proxy materials will be issued to all stockholders of record as of the new record date.
  • Revelation Biosciences is a clinical-stage life sciences company utilizing its proprietary formulation Gemini to rebalance inflammation.
  • The company is evaluating Gemini for prevention of post-surgical infection, prevention of acute kidney injury, & treatment of chronic kidney disease.
  • Forward-looking statements in the release are subject to risks including competition, enrollment challenges, adverse safety events, regulatory approval uncertainties, & potential NASDAQ listing maintenance issues.